+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Neuropathic Pain Drug Market Research Report by Type, Treatment, Indication, Diagnosis, Distribution, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 234 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4968619
UP TO OFF until Dec 31st 2022
The Global Neuropathic Pain Drug Market size was estimated at USD 9,614.04 million in 2021, USD 10,526.47 million in 2022, and is projected to grow at a CAGR 9.66% to reach USD 16,725.38 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Neuropathic Pain Drug to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Phantom Limb Pain, Post Herpetic Neuralgia, Post-traumatic Neuropathy, and Trigeminal Neuralgia.
  • Based on Treatment, the market was studied across Antidepressant Drugs Type, Medication Type, Multimodal Therapy, and NSAIDs Type. The Antidepressant Drugs Type is further studied across Serotonin Noradrenaline and Tricyclic Antidepressants. The NSAIDs Type is further studied across Ibuprofen and Naproxen.
  • Based on Indication, the market was studied across Diabetic Neuropathy and Spinal Stenosis.
  • Based on Diagnosis, the market was studied across Blood Tests and Imaging Physical Examination. The Imaging Physical Examination is further studied across CT, Electromyography, and MRI.
  • Based on Distribution, the market was studied across Online Pharmacies and Retail Pharmacies & Drug Stores.
  • Based on End User, the market was studied across Clinics and Hospitals.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Neuropathic Pain Drug market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neuropathic Pain Drug Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuropathic Pain Drug Market, including Abbott, Allergan, Inc., Astellas, AstraZeneca, Bausch Health Companies Inc., Baxter Healthcare Corporation, Biogen Idec Inc., Bristol-Myers Squibb and Company, Cara Therapeutics, CODA Biotherapeutics, Inc., Collegium Pharmaceuticals, Depomed, Depomed Inc., Eli Lily and Company, Endo International plc, GlaxoSmithKline PLC, Grünenthal, GSK, Johnson & Johnson Services Inc., Mallinckrodt Pharmaceuticals, Neuroheal Biomedicals, Novartis International AG, Pacira BioSciences, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., and Teva Pharmaceutical Industries Ltd.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Neuropathic Pain Drug Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuropathic Pain Drug Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuropathic Pain Drug Market?
4. What is the competitive strategic window for opportunities in the Global Neuropathic Pain Drug Market?
5. What are the technology trends and regulatory frameworks in the Global Neuropathic Pain Drug Market?
6. What is the market share of the leading vendors in the Global Neuropathic Pain Drug Market?
7. What modes and strategic moves are considered suitable for entering the Global Neuropathic Pain Drug Market?
Frequently Asked Questions about the Global Neuropathic Pain Drug Market

What is the estimated value of the Global Neuropathic Pain Drug Market?

The Global Neuropathic Pain Drug Market was estimated to be valued at $9614.04 Million in 2021.

What is the growth rate of the Global Neuropathic Pain Drug Market?

The growth rate of the Global Neuropathic Pain Drug Market is 9.6%, with an estimated value of $16725.38 Million by 2027.

What is the forecasted size of the Global Neuropathic Pain Drug Market?

The Global Neuropathic Pain Drug Market is estimated to be worth $16725.38 Million by 2027.

Who are the key companies in the Global Neuropathic Pain Drug Market?

Key companies in the Global Neuropathic Pain Drug Market include Abbott, Allergan, Inc., Astellas, AstraZeneca, Bausch Health Companies Inc., Baxter Healthcare Corporation, Biogen Idec Inc., Bristol and Cara Therapeutics.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Prevalence of Chronic Diseases Such as Diabetes and Cancer Globally
5.1.1.2. Rising Advancement of Healthcare Systems Across the World
5.1.1.3. Availability of Numerous Approved Drugs at Retail Pharmacies
5.1.2. Restraints
5.1.2.1. Probable Side Effects That Could Lead to Death
5.1.3. Opportunities
5.1.3.1. Surge in Awareness Related to Neuropathic Pain in Emerging Economies
5.1.3.2. Ongoing Technological Innovations and Development of Drugs
5.1.4. Challenges
5.1.4.1. Concerns Over Incomplete Pain Relief
5.2. Cumulative Impact of COVID-19
6. Neuropathic Pain Drug Market, by Type
6.1. Introduction
6.2. Phantom Limb Pain
6.3. Post Herpetic Neuralgia
6.4. Post-Traumatic Neuropathy
6.5. Trigeminal Neuralgia
7. Neuropathic Pain Drug Market, by Treatment
7.1. Introduction
7.2. Antidepressant Drugs Type
7.2.1. Serotonin Noradrenaline
7.2.2. Tricyclic Antidepressants
7.3. Medication Type
7.4. Multimodal Therapy
7.5. NSAIDs Type
7.5.1. Ibuprofen
7.5.2. Naproxen
8. Neuropathic Pain Drug Market, by Indication
8.1. Introduction
8.2. Diabetic Neuropathy
8.3. Spinal Stenosis
9. Neuropathic Pain Drug Market, by Diagnosis
9.1. Introduction
9.2. Blood Tests
9.3. Imaging Physical Examination
9.3.1. Ct
9.3.2. Electromyography
9.3.3. Mri
10. Neuropathic Pain Drug Market, by Distribution
10.1. Introduction
10.2. Online Pharmacies
10.3. Retail Pharmacies & Drug Stores
11. Neuropathic Pain Drug Market, by End-user
11.1. Introduction
11.2. Clinics
11.3. Hospitals
12. Americas Neuropathic Pain Drug Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Neuropathic Pain Drug Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
14. Europe, Middle East & Africa Neuropathic Pain Drug Market
14.1. Introduction
14.2. France
14.3. Germany
14.4. Italy
14.5. Netherlands
14.6. Qatar
14.7. Russia
14.8. Saudi Arabia
14.9. South Africa
14.10. Spain
14.11. United Arab Emirates
14.12. United Kingdom
15. Competitive Landscape
15.1. Fpnv Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, by Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Abbott
16.2. Allergan, Inc.
16.3. Astellas
16.4. Astrazeneca
16.5. Bausch Health Companies Inc.
16.6. Baxter Healthcare Corporation
16.7. Biogen Idec Inc.
16.8. Bristol-Myers Squibb and Company
16.9. Cara Therapeutics
16.10. Coda Biotherapeutics, Inc.
16.11. Collegium Pharmaceuticals
16.12. Depomed
16.13. Depomed Inc.
16.14. Eli Lily and Company
16.15. Endo International plc
16.16. GlaxoSmithKline plc
16.17. Grünenthal
16.18. Gsk
16.19. Johnson & Johnson Services Inc.
16.20. Mallinckrodt Pharmaceuticals
16.21. Neuroheal Biomedicals
16.22. Novartis International Ag
16.23. Pacira Biosciences
16.24. Pfizer Inc.
16.25. Purdue Pharma L.P.
16.26. Sanofi S.A.
16.27. Teva Pharmaceutical Industries Ltd
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL NEUROPATHIC PAIN DRUG MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL NEUROPATHIC PAIN DRUG MARKET DYNAMICS
FIGURE 8. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2027
FIGURE 11. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY PHANTOM LIMB PAIN, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY PHANTOM LIMB PAIN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST HERPETIC NEURALGIA, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST HERPETIC NEURALGIA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST-TRAUMATIC NEUROPATHY, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST-TRAUMATIC NEUROPATHY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRIGEMINAL NEURALGIA, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2021 VS 2027 (%)
FIGURE 20. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2021 VS 2027 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2027
FIGURE 22. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SEROTONIN NORADRENALINE, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SEROTONIN NORADRENALINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MEDICATION TYPE, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MEDICATION TYPE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MULTIMODAL THERAPY, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MULTIMODAL THERAPY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NSAIDS TYPE, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NSAIDS TYPE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IBUPROFEN, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IBUPROFEN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NAPROXEN, 2019-2027 (USD MILLION)
FIGURE 37. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NAPROXEN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 39. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2027
FIGURE 41. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIABETIC NEUROPATHY, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIABETIC NEUROPATHY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SPINAL STENOSIS, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SPINAL STENOSIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2021 VS 2027 (%)
FIGURE 46. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2021 VS 2027 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2027
FIGURE 48. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY BLOOD TESTS, 2019-2027 (USD MILLION)
FIGURE 49. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY BLOOD TESTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 50. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IMAGING PHYSICAL EXAMINATION, 2019-2027 (USD MILLION)
FIGURE 51. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IMAGING PHYSICAL EXAMINATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 52. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY CT, 2019-2027 (USD MILLION)
FIGURE 53. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY CT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 54. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ELECTROMYOGRAPHY, 2019-2027 (USD MILLION)
FIGURE 55. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ELECTROMYOGRAPHY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 56. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MRI, 2019-2027 (USD MILLION)
FIGURE 57. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MRI, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 58. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 59. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD MILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2027
FIGURE 61. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 62. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 63. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, 2019-2027 (USD MILLION)
FIGURE 64. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 65. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 66. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 67. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2027
FIGURE 68. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY CLINICS, 2019-2027 (USD MILLION)
FIGURE 69. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY CLINICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 70. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 71. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 72. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 74. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY COUNTRY, 2027
FIGURE 76. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 82. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 83. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY STATE, 2027
FIGURE 84. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 86. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 87. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY COUNTRY, 2027
FIGURE 88. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 91. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 92. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 93. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 94. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 95. SINGAPORE NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 96. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 97. TAIWAN NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 98. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 99. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 100. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 101. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 102. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY COUNTRY, 2027
FIGURE 103. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 104. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 105. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 106. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 107. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 108. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 109. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 110. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 111. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 112. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 113. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 114. GLOBAL NEUROPATHIC PAIN DRUG MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 115. GLOBAL NEUROPATHIC PAIN DRUG MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 116. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL NEUROPATHIC PAIN DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY PHANTOM LIMB PAIN, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY PHANTOM LIMB PAIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY PHANTOM LIMB PAIN, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY PHANTOM LIMB PAIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY PHANTOM LIMB PAIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST HERPETIC NEURALGIA, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST HERPETIC NEURALGIA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST HERPETIC NEURALGIA, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST HERPETIC NEURALGIA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST HERPETIC NEURALGIA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST-TRAUMATIC NEUROPATHY, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST-TRAUMATIC NEUROPATHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST-TRAUMATIC NEUROPATHY, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST-TRAUMATIC NEUROPATHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST-TRAUMATIC NEUROPATHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SEROTONIN NORADRENALINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY SEROTONIN NORADRENALINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY SEROTONIN NORADRENALINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY SEROTONIN NORADRENALINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY SEROTONIN NORADRENALINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MEDICATION TYPE, BY REGION, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY MEDICATION TYPE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY MEDICATION TYPE, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY MEDICATION TYPE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY MEDICATION TYPE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MULTIMODAL THERAPY, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY MULTIMODAL THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY MULTIMODAL THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY MULTIMODAL THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY MULTIMODAL THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NSAIDS TYPE, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY NSAIDS TYPE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY NSAIDS TYPE, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY NSAIDS TYPE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY NSAIDS TYPE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IBUPROFEN, BY REGION, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY IBUPROFEN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY IBUPROFEN, BY STATE, 2019-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY IBUPROFEN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY IBUPROFEN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NAPROXEN, BY REGION, 2019-2027 (USD MILLION)
TABLE 63. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY NAPROXEN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY NAPROXEN, BY STATE, 2019-2027 (USD MILLION)
TABLE 65. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY NAPROXEN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY NAPROXEN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 68. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIABETIC NEUROPATHY, BY REGION, 2019-2027 (USD MILLION)
TABLE 69. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIABETIC NEUROPATHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIABETIC NEUROPATHY, BY STATE, 2019-2027 (USD MILLION)
TABLE 71. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIABETIC NEUROPATHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIABETIC NEUROPATHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SPINAL STENOSIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 74. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY SPINAL STENOSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY SPINAL STENOSIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 76. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY SPINAL STENOSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY SPINAL STENOSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 79. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY BLOOD TESTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 80. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY BLOOD TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY BLOOD TESTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 82. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY BLOOD TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY BLOOD TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 84. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IMAGING PHYSICAL EXAMINATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 85. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY IMAGING PHYSICAL EXAMINATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY IMAGING PHYSICAL EXAMINATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 87. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY IMAGING PHYSICAL EXAMINATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY IMAGING PHYSICAL EXAMINATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 89. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY CT, BY REGION, 2019-2027 (USD MILLION)
TABLE 90. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY CT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 91. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY CT, BY STATE, 2019-2027 (USD MILLION)
TABLE 92. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY CT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY CT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 94. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ELECTROMYOGRAPHY, BY REGION, 2019-2027 (USD MILLION)
TABLE 95. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY ELECTROMYOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 96. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY ELECTROMYOGRAPHY, BY STATE, 2019-2027 (USD MILLION)
TABLE 97. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY ELECTROMYOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY ELECTROMYOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 99. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MRI, BY REGION, 2019-2027 (USD MILLION)
TABLE 100. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY MRI, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 101. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY MRI, BY STATE, 2019-2027 (USD MILLION)
TABLE 102. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY MRI, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY MRI, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 104. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 105. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 106. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 107. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 108. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 110. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2019-2027 (USD MILLION)
TABLE 111. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 112. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY STATE, 2019-2027 (USD MILLION)
TABLE 113. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 115. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 116. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY CLINICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 117. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 118. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 119. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 121. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 122. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 123. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 124. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 126. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 127. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 128. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 129. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 130. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 131. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 132. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 133. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 134. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 135. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 136. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 137. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 138. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 139. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 140. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 141. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 142. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 143. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 144. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 145. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 146. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 147. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 148. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 149. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 150. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 151. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 152. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 153. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 154. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 155. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 156. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 157. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 158. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 159. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 160. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 161. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 162. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 163. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 164. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 165. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 166. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 167. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 168. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 169. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 170. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 171. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 172. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 173. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 174. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 175. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 176. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 177. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 178. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 179. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 180. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 181. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 182. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 183. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 184. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 185. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 186. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 187. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 188. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 189. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 190. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 191. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 192. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 193. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 194. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 195. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 196. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 197. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 198. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 199. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 200. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 201. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 202. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 203. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 204. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 205. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 206. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 207. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 208. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 209. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 210. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 211. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 212. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 213. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 214. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 215. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 216. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 217. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 218. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 219. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 220. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 221. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 222. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 223. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 224. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 225. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 226. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 227. SINGAPORE NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 228. SINGAPORE NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 229. SINGAPORE NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 230. SINGAPORE NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 231. SINGAPORE NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 232. SINGAPORE NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 233. SINGAPORE NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 234. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 235. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 236. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 237. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 238. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 239. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 240. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 241. TAIWAN NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 242. TAIWAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 243. TAIWAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 244. TAIWAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 245. TAIWAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 246. TAIWAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 247. TAIWAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 248. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 249. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 250. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 251. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 252. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 253. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 254. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 263. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 264. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 265. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 266. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 267. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 268. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 269. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 270. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 271. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 272. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 273. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 274. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 275. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 276. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 277. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 278. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 279. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 280. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 281. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 282. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 283. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 284. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 285. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 286. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 287. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 288. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 289. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 290. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 291. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 292. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 293. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 294. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 295. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 296. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 297. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 298. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 299. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 300. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 301. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 302. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 303. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 304. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 305. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 306. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 307. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 308. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 309. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 310. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 311. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 312. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 313. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 314. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 315. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 316. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 317. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 318. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 319. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 320. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 321. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 322. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 323. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2019-2027 (USD MILLION)
TABLE 324. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 325. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZ

Companies Mentioned

  • Abbott
  • Allergan, Inc.
  • Astellas
  • AstraZeneca
  • Bausch Health Companies Inc.
  • Baxter Healthcare Corporation
  • Biogen Idec Inc.
  • Bristol-Myers Squibb and Company
  • Cara Therapeutics
  • CODA Biotherapeutics, Inc.
  • Collegium Pharmaceuticals
  • Depomed
  • Depomed Inc.
  • Eli Lily and Company
  • Endo International plc
  • GlaxoSmithKline PLC
  • Grünenthal
  • GSK
  • Johnson & Johnson Services Inc.
  • Mallinckrodt Pharmaceuticals
  • Neuroheal Biomedicals
  • Novartis International AG
  • Pacira BioSciences
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd

Methodology

Loading
LOADING...